MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$79.03

Market cap

$105.15B

P/E Ratio

29.06

Dividend/share

$2.74

EPS

$2.72

Enterprise value

$128.8B

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
Medtronic's quick ratio has increased by 50% YoY
The price to earnings (P/E) is 12% lower than the 5-year quarterly average of 33.5
The EPS has declined by 30% year-on-year and by 3.9% since the previous quarter
The net income has contracted by 30% YoY and by 3.7% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com
Peers: BSX SYK EW JNJ

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.33B
Market cap
$105.15B
Enterprise value
$128.8B
Valuations
Price to earnings (P/E)
29.06
Price to book (P/B)
2.05
Price to sales (P/S)
3.33
EV/EBIT
21.09
EV/EBITDA
14.62
EV/Sales
4.08
Earnings
Revenue
$31.56B
EBIT
$6.11B
EBITDA
$8.81B
Free cash flow
$4.44B
Per share
EPS
$2.72
Free cash flow per share
$3.34
Book value per share
$38.47
Revenue per share
$23.72
TBVPS
$26.24
Balance sheet
Total assets
$90.78B
Total liabilities
$39.41B
Debt
$24.98B
Equity
$51.18B
Working capital
$12.82B
Liquidity
Debt to equity
0.49
Current ratio
2.42
Quick ratio
1.51
Net debt/EBITDA
2.68
Margins
EBITDA margin
27.9%
Gross margin
65.7%
Net margin
11.5%
Operating margin
17.8%
Efficiency
Return on assets
3.9%
Return on equity
7%
Return on invested capital
12.9%
Return on capital employed
7.5%
Return on sales
19.3%
Dividend
Dividend yield
3.47%
DPS
$2.74
Payout ratio
100.7%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
-1.18%
1 week
-4.36%
1 month
-3.84%
1 year
-2.83%
YTD
1.69%
QTD
-10.3%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$31.56B
Gross profit
$20.73B
Operating income
$5.63B
Net income
$3.62B
Gross margin
65.7%
Net margin
11.5%
MDT's net margin is down by 32% year-on-year and by 4.2% since the previous quarter
The net income has contracted by 30% YoY and by 3.7% from the previous quarter
The operating margin has declined by 8% year-on-year
The operating income has decreased by 6% YoY but it has increased by 2.6% QoQ

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
MDT P/E details
P/E
29.06
P/B
2.05
P/S
3.33
EV/EBIT
21.09
EV/EBITDA
14.62
EV/Sales
4.08
The EPS has declined by 30% year-on-year and by 3.9% since the previous quarter
The price to earnings (P/E) is 12% lower than the 5-year quarterly average of 33.5
The stock's price to book (P/B) is 23% less than its 5-year quarterly average of 2.7 and 10% less than its last 4 quarters average of 2.3
The company's equity fell by 2.8% YoY
MDT's P/S is 25% lower than its 5-year quarterly average of 4.5 and 9% lower than its last 4 quarters average of 3.7

Efficiency

How efficient is Medtronic business performance
MDT's return on assets is down by 32% year-on-year and by 4.9% since the previous quarter
Medtronic's return on equity has decreased by 29% YoY and by 2.8% QoQ
The company's return on invested capital fell by 8% YoY and by 3% QoQ
The return on sales has declined by 4.5% year-on-year

Dividends

What is MDT's dividend history
Dividend details
DPS
$2.74
Dividend yield
3.47%
Payout ratio
100.7%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 130% greater than the total liabilities
The company's current ratio has surged by 53% YoY
Medtronic's quick ratio has increased by 50% YoY
MDT's debt is 51% smaller than its equity
Medtronic's debt to equity has increased by 11% YoY and by 4.3% from the previous quarter
MDT's debt is up by 8% year-on-year and by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.